isomethyleugenol has been researched along with Polycystic Kidney, Autosomal Dominant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flanagan, C; Kerr, K; Maxwell, AP; McAneney, H; McKnight, AJ | 1 |
| Calvet, JP; Fan, LX; Grantham, JJ; Li, LX; Li, X; Sage, J; Zhou, JX | 1 |
1 review(s) available for isomethyleugenol and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review.
Topics: Biomarkers; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Kidney; Kidney Diseases; Methylation; Polycystic Kidney, Autosomal Dominant; Proteinuria; Rare Diseases | 2019 |
1 other study(ies) available for isomethyleugenol and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Topics: Animals; Benzoxazines; beta-Alanine; Cell Proliferation; Cysts; Epigenesis, Genetic; Epithelial Cells; Histone-Lysine N-Methyltransferase; MAP Kinase Signaling System; Methylation; Mice; Mice, Mutant Strains; Polycystic Kidney, Autosomal Dominant; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Transcription Factor RelA; TRPP Cation Channels | 2017 |